BSEEvoq Remedies LtdMinimalNeutral
Announced Fri, 10 Oct · 11:33 IST

Compliance Certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Evoq Remedies Ltd submitted to BSE a compliance certificate under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018, for the quarter ended 30th September 2025. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), M/s. Accurate Securities & Registry Private Limited, and was signed by Managing Director Bhumishth Patel on 10th October 2025. This is a routine quarterly compliance filing required for companies whose shares are held in dematerialized (demat) form with depositories.

Likely market impact

This is a standard regulatory compliance filing with no material impact on the stock price, business operations, or shareholders. Investors can ignore this as routine housekeeping.